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Synopsis
The bacterial stringent response is induced by nutrient deprivation and is mediated by enzymes of the RSH (RelA/SpoT
homologue; RelA, (p)ppGpp synthetase I; SpoT, (p)ppGpp synthetase II) superfamily that control concentrations of the
‘alarmones’ (p)ppGpp (guanosine penta- or tetra-phosphate). This regulatory pathway is present in the vast majority
of pathogens and has been proposed as a potential anti-bacterial target. Current understanding of RelA-mediated
responses is based on biochemical studies using Escherichia coli as a model. In comparison, the Francisella tularensis
RelA sequence contains a truncated regulatory C-terminal region and an unusual synthetase motif (EXSD). Biochemical
analysis of F. tularensis RelA showed the similarities and differences of this enzyme compared with the model RelA from
Escherichia coli. Purification of the enzyme yielded a stable dimer capable of reaching concentrations of 10 mg/ml.
In contrast with other enzymes from the RelA/SpoT homologue superfamily, activity assays with F. tularensis RelA
demonstrate a high degree of specificity for GTP as a pyrophosphate acceptor, with no measurable turnover for GDP.
Steady state kinetic analysis of F. tularensis RelA gave saturation activity curves that best fitted a sigmoidal function.
This kinetic profile can result from allosteric regulation and further measurements with potential allosteric regulators
demonstrated activation by ppGpp (5′,3′-dibisphosphate guanosine) with an EC50 of 60 +− 1.9 μM. Activation of F.
tularensis RelA by stalled ribosomal complexes formed with ribosomes purified from E. coli MRE600 was observed,
but interestingly, significantly weaker activation with ribosomes isolated from Francisella philomiragia.
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INTRODUCTION
Bacteria rely on global metabolic regulation by the stringent
response for survival as the environment becomes nutrient de-
ficient [1,2]. This response is orchestrated by the synthesis
and subsequent downstream effects of the signalling molecules
guanosine penta- and tetra-phosphate [ collectively known as
(p)ppGpp; 3]. In β- and γ -proteobacteria, synthesis of these sig-
nalling molecules is catalysed by the enzymes RelA and SpoT,
members of the long RelA/SpoT homologue (RSH) superfamily
[4]. Virtually ubiquitous across bacterial species, RSH proteins
have been suggested as prospective novel anti-bacterial targets,
with genetic knockouts showing attenuation in animal infection
models [5–8].
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In Escherichia coli, and by inference other β- and γ -
proteobacteria, the enzyme RelA is principally responsible for
(p)ppGpp synthesis during amino acid starvation [9]. Since its
discovery [10], the mechanism by which RelA activation leads to
(p)ppGpp accumulation has been extensively studied [11–14]. A
working hypothesis for RelA activation proposes that the enzyme
is most active following its release from a stalled ribosomal com-
plex [11,15] (Figure 1A). This hypothesis, termed the ‘extended
hopping model’ [15], explains how the bacterium can respond
to a reduced level of amino acids by sensing a hiatus in protein
synthesis and is supported by both in vitro [11–13] and in vivo
[15] experimental evidence.
The protein sequence for long RSH proteins [4] can be
divided into an N-terminal region (containing catalytic sites)
and a C-terminal region [containing regulatory threonyl-tRNA
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Figure 1 The extended hopping model for RelA activation, derived from the proposal of English et al. [15]
Under conditions of amino acid starvation, unacylated-tRNA accumulates and binds to the acceptor (A) site of the ribosome,
leading to stalling. This results in the release of RelA from the ribosome in an activated conformation, which catalyses
the formation of (p)ppGpp. (B) Domain structure and corresponding amino acids for EcRelA and FtRelA. (C) Alignment of
RelA enzymes synthetase domain active-site motif from pathogenic bacteria.
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synthetase, GTPase and SpoT domain (TGS), conserved cysteine
domain (CC), helical and aspartate kinase, chorismate mutase,
TyrA domain (ACT) domains] connected by a linker region
(Figure 1B) [4]. Long RSH proteins can be divided into bi-
functional (Rel or SpoT) or mono-functional (RelA) enzymes.
Both classes are capable of synthesizing (p)ppGpp but only
bifunctional enzymes are capable of (p)ppGpp hydrolysis [16].
Studies with RelA fragments indicate the C-terminal region func-
tions to regulate the catalytic synthetase domain [17] and contains
the recognition features that permit homodimerization [18].
F. tularensis RelA (FtRelA) contains a truncated C-terminal
region, approximately 100 amino acids shorter than most RelAs
and is one of only three RelA sequences known to not contain
an ACT domain [4] (Figure 1B). Proteins containing ACT do-
mains can be found throughout nature, displaying a conserved
βαββαβ fold of the domain and are involved in small molecule
ligand recognition [19,20]. This domain originally described as
a ‘conserved, evolutionary mobile module’ is proposed to have
evolutionarily fused with proteins to facilitate the regulation of
their catalytic activity by the allosteric binding of small molecules
[21].
Besides its truncated C-terminal region FtRelA differs from
the majority of other RelA enzymes in its synthetase active-site
motif. The synthetase domain from RSH proteins are reported
to contain either an RXKD or an EXDD motif, which are in-
volved in the preferential binding of the pyrophosphate acceptor
(i.e. GDP or GTP) [22]. In contrast, the synthetase domain in
FtRelA contains the alternative EXSD motif (Figure 1C), which
interestingly can be found in a wide spectrum of Francisella spe-
cies (Supplementary Figure S1). This alternative motif shows the
replacement of the initial aspartate with a serine. The primary as-
partate has been proposed to allow the co-ordination of a second
magnesium ion [23]. The difference in this active-site motif in
FtRelA raised the question of whether the (p)ppGpp synthetase
activity in the presence of an EXSD motif is more closely aligned
to the RSH enzymes featuring RXKD or EXDD motifs.
The functional analysis of FtRelA, described herein, offers
insights into the importance of the distinctive sequence of the
synthetase domain and the absence of the ACT domain, compared
with other RelA enzymes.
MATERIALS AND METHODS
DTT, BSA and antibiotics were purchased from Melford Labor-
atories; polyacrylamide-bis polyacrylamide [30 % (w/v), 37:5:1],
Bacto tryptone and yeast extract for culture media were purchased
from Oxoid. Chelating fast flow resin and Superdex 200 resin
were purchased from GE Healthcare; primers were purchased
from Eurofins; restriction enzymes and E. coli strain K12 JM109
were purchased from New England Biolabs; pET16b plasmid
was purchased from Merck Chemicals; E. coli RelA was ex-
pressed using a strain from the ASKA Clone library purchased
from Shigen; E. coli MRE600 (C6) strain was purchased from
NCTC. Francisella philomiragia was obtained from A.T.C.C.;
mRNA was purchased from ATDBio. Unless stated otherwise
all other reagents were purchased from Sigma–Aldrich or Fisher
Scientific. Graphpad Prism version 6 for Windows was obtained
from Graphpad Software.
Cloning of F. tularensis RelA
The gene encoding FtRelA, FTT_1508c, was amplified from F.
tularensis subspecies tularensis SCHU S4 genomic DNA us-
ing a forward primer (5′- ccgccatgggtcatcatcatcatcatcatcaagt-
tattgactctaaacttctagatagt) paired with a reverse primer (5′-
cgcctcgagttagctgacctcttcattatcatc). The PCR product was diges-
ted with NcoI and XhoI and the resultant fragment was ligated
into a backbone derived from NcoI/XhoI restricted pET16b. The
sequence of the resultant plasmid pET16b::relA was verified by
sequencing.
Expression of FtRelA
The plasmid pET16b::relA was chemically transformed into E.
coli BL21 (DE3) pLysS competent cells (Sigma–Aldrich). Single
colonies were used to inoculate 2YT media [24] (10 ml, contain-
ing 100 μg/ml ampicillin and 30 μg/ml chloramphenicol) and
cultured overnight at 37 ◦C. The overnight culture was used as
a 1 % inoculum for flasks of 2YT (4 × 1.25 litre) which were
induced with IPTG (final concentration of 0.4 mM) when the ab-
sorbance at 600 nm (A600) reached 0.6 and then cultured overnight
at 16 ◦C. The cell pellet was then collected by centrifugation (av-
erage yield of 5 g/ 1 litre of culture) and stored at –80 ◦C.
Purification of FtRelA
Frozen cell pellet (typically 15 g) was resuspended (3 × v/w cell
pellet) in buffer A [50 mM Tris, pH 8.0, 500 mM NaCl, 3 mM
β-mercaptoethanol, 15 % (v/v) glycerol and 20 mM imidazole].
Lysozyme (5–15 mg) and a Roche protease inhibitor tablet (1
per 50 ml) were added to the cell suspension and left to stir
(4 ◦C, 30 min). Cells were lysed by sonication (4 ◦C, 20 × 30 s
with 30 s rest) and cellular debris removed by centrifugation
(23 446 g, 4 ◦C, 30 min). The resultant cleared lysate was applied
(4 ml·min− 1) to a Ni-IDA (iminodiacetic acid) Sepharose Fast
Flow Column (50 ml bed volume). The column was then washed
(4 ml·min− 1) with buffer A until the absorption of the eluate
at 280 nm (A280) returned to baseline. Elution (4 ml·min− 1) of
FtRelA was achieved using a gradient of imidazole from 20 to
500 mM (buffer B, as buffer A but with 500 mM imidazole) over
5 column volumes. Fractions containing FtRelA were pooled
and dialysed against buffer C [2 × 1 litre, 50 mM Tris, pH 8.0,
300 mM NaCl, 1 mM DTT, 15 % (v/v) glycerol] and concen-
trated to 10–15 mg/ml in an Amicon Pressure Cell (30 kDa PES
filter, Sartorius) before overnight storage at 4 ◦C. The concen-
trated FtRelA (3 ml) was then applied (2 ml·min− 1) to a gel
filtration column (HiLoad 26/60, Superdex 200, prep grade) pre-
equilibrated in buffer C. The purest fractions of FtRelA, as judged
by SDS/PAGE, were pooled and concentrated (as described
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above) to ∼4 mg/ml (∼50 μM), then aliquoted (typically 0.2 ml)
and stored at –80 ◦C. For biochemical experiments, FtRelA ali-
quots were defrosted and used only once. Each batch of FtRelA
was used within 8 weeks of freezing.
Characterization of FtRelA multimeric state by gel
filtration
A Superdex 200 column (10 mm × 300 mm) was used to estim-
ate the apparent molecular mass of purified FtRelA (∼1 mg/ml,
∼13.5 μM). Protein samples were applied (1 ml·min− 1) to a
pre-equilibrated column in buffer D (50 mM Tris/HCl, pH 7.5,
100 mM KCl). Cytochrome C, carbonic anhydrase, BSA, alco-
hol dehydrogenase and β-amylase (Sigma–Aldrich) were used
as protein standards for calibration of the column. Elution of the
protein samples were monitored by absorbance at 280 nm.
HPLC analysis of FtRelA activity
FtRelA activity assays, substrate specificity assays and assays to
identify and quantify activating factors were all analysed by IP RP
(ion pair reverse phase) HPLC, using methods adapted from Cor-
dell et al. [25]. Injected samples (40 μl) were chromatographed
on a reverse phase column [Gemini C18, 150 × 4.6 mm2 5 micron
(Phenomenex)] at a flow rate of 0.8 ml·min− 1 with UV detection
at 260 nm. The mobile aqueous phase was 95 % water with 5 %
methanol and organic phase was 20 % water with 80 % meth-
anol. Both phases contained DMHA (N,N-dimethylhexylamine;
15 mM) and were adjusted to pH 7.0 with acetic acid. Nts were
eluted with the following gradient: 0–5 min, isocratic, 25 % or-
ganic buffer; 5–27 min, gradient 25 %–60 %; 27–28 min, gradient
60 %–100 %; 28–33 min, isocratic, 100 %; 33–34 min, gradient
100%-25%; 34–44 min, isocratic 25 %.
Substrate specificity of FtRelA
Reaction mixtures (100 μl) were prepared with components at
the following final concentrations: ribonucleotide di- or triphos-
phates (2 mM, either G, T or C), ATP (2 mM) and FtRelA
(10 μM) in assay buffer (20 mM Tris, pH 8.0, 15 mM KCl,
15 mM MgCl2, 1 mM β-mercaptoethanol). Reactions were in-
cubated at 30 ◦C for 60 min, prior to quenching by heating. All
reactions quenched by heat were maintained at 80 ◦C for 2 min.
The reaction mixtures were then kept on ice to ensure full protein
precipitation (typically 10 min), before clearing by centrifugation
(13 684 g, 4 ◦C, 5 min). An aliquot (40 μl) of the supernatant was
then analysed by IP RP HPLC. Assays to determine substrate
selectivity under modified conditions are described in ‘Supple-
mentary Methods’ 1 and 2.
Steady state kinetics for FtRelA and substrates
Reaction mixtures for time course experiments (1 ml) contained
FtRelA (10 μM) and were made up in assay buffer. When satur-
ating, nts (GTP or ATP) were included at 2 mM. Reactions were
incubated at 30 ◦C and at selected time points, aliquots (100 μl)
were withdrawn and reaction quenched by heating. Precipitated
protein was removed as described above and a sample (40 μl)
was analysed by IP RP HPLC. The concentrations of nts were
quantified by comparison with a standard calibration curve. The
formation of product nts over time (never more than 15 % sub-
strate turnover) was fitted to a linear function to determine initial
rates (Supplementary Table S1). Initial rates, v, were fitted to
an allosteric sigmoidal function (eqn 1) using Graphpad Prism
software where Vmax is the rate of reaction at substrate saturation,
K1/2 is the concentration of substrate giving a rate of half of Vmax
and h is the apparent Hill constant.
v = Vmax S
h
(
K h1/2 + S
h
) (1)
[31P]-NMR analysis of FtRelA activity
FtRelA-catalysed reaction time courses were monitored with
[31P]-NMR. All data were recorded on a Bruker AVII400 FT-
NMR Spectrometer using a 10-mm auto-tune and match broad-
band probe tuned to the sample prior to data collection (data ac-
quisition size = 65536 points; sweep width = 395 ppm; 512 scans
using 90◦ pulse with a total acquisition time of 2.5 s per scan;
chemical shifts referenced to H3PO4). Reaction mixtures (3 ml)
were prepared in assay buffer and contained GTP (2 mM), ATP
(2 mM) and 10 % 2H2O. The reaction was initiated through the
addition of FtRelA (10 μM), thoroughly mixed and then data col-
lected at 25 ◦C for 22 min followed by 22 min bins for the duration
of the experiment (typically 110 min). Peak integrals were calib-
rated against a spectrum recorded prior to initiation. At each sub-
strate concentration, the formation of product nts over time was
fitted to a linear function to determine the rate of product forma-
tion. These rates were then fitted to an allosteric sigmoidal curve
(eqn 1).
Expression and purification of ribosomes
Ribosomes were isolated from both F. philomiragia and E.
coli MRE600. For the purification of ribosomes from E. coli,
overnight cultures of E. coli MRE600 (LB media, 10 ml) were
used to inoculate flasks of LB media (1 litre) supplemented with
MgSO4 (10 mM). Cultures were grown at 37 ◦C to an A600 of
0.4; cells were then pelleted by centrifugation (3501 g, 4 ◦C,
30 min). For the purification of ribosomes from F. philomira-
gia, overnight cultures of F. philomiragia [trypticase soy broth
(TSB), 10 ml] were used to inoculate flasks of TSB (1 litre) sup-
plemented with L-cysteine (1 g/l). Culture was grown at 37 ◦C
to an A600 of 1.0 and the cells collected by centrifugation as de-
scribed above. Cell pellets were washed and stored as described
by Maguire et al. [26]. SulfoLink-cysteine resin was prepared
and ribosomes purified as described for E. coli ribosomes by
Maguire et al. [26]. Fractions (10 ml) containing ribosomes, as
assessed by absorption at 260 nm, SDS/PAGE and measurement
of protein content by the method of Bradford [27], were pooled
and concentrated to 4.96 and 8.93 μM for F. philomiragia and E.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
Francisella tularensis RelA is distinct from the model RelA
coli respectively in an Amicon Pressure Cell (30 kDa PES filter,
Sartorius). Concentrated ribosomes were aliquoted (200 μL) and
stored at –80 ◦C. RNA was isolated from ribosomal samples using
the GeneJet RNA purification kit (Thermo Scientific) and ana-
lysed by bleach RNA gel electrophoresis as described by Aranda
et al. [28].
Ribosome-activated FtRelA activity assays
Reaction mixtures containing stalled ribosomal complexes
were prepared in assay buffer with purified ribosomes
(0.2 μM), purified RelA (0.5 μM), ATP (2 mM) and each
RNA species (0.3 μM). RNA species include: mRNA (5′-
caaggagguaaaaauggucgucgcacgu) [12], tRNAfmet (from E. coli
MRE600) and tRNAval (from E. coli MRE600). Reaction mix-
tures were incubated at 30 ◦C for 5 min prior to initiation
by the addition of GTP (2 mM final concentration). Reac-
tion mixtures were incubated for 60 min at 30 ◦C prior to
quenching by heating. Precipitated protein was removed as de-
scribed above and a sample (40 μl) was analysed by IP RP
HPLC.
Product activation of FtRelA
The nt ppGpp (5′,3′-dibisphosphate guanosine) was synthesized
and purified as described by Carmona et al. [29] with minor
modifications (Supplementary Method S3). Reaction mixtures
(100 μl) were prepared in assay buffer with components at the fol-
lowing final concentrations: ribonucleotide triphosphates (2 mM,
both A and G), FtRelA (5 μM) and purified ppGpp, AMP or
KH2PO4 (at indicated concentrations). Reactions were incub-
ated at 30 ◦C for 60 min prior to quenching by heating. Protein
was precipitated and removed from samples as detailed above,
prior to analysis of the sample by IP RP HPLC. Assays were
prepared alongside a negative control containing no additional
small molecular component. The EC50 value was calculated with
a sigmoidal dose-response (variable slope) curve (eqn 2), using
Graphpad Prism software where Y is the rate, Ymax is the max-
imum rate, Ymin is the basal rate and EC50 is the concentration
of ligand required to give 50 % of full activation and h is the
apparent Hill slope.
Y = Ymin + (Ymax − Ymin)
1 + 10(LogEC50 − X) − h
(2)
RESULTS
Expression and purification of FtRelA
The RelA encoding gene, FTT_1508c, from F. tularensis sub-
species tularensis SCHU S4 was cloned with primers designed
to encode an N-terminal His6-tag to facilitate subsequent pro-
tein purification. Optimized expression of FtRelA in E. coli
BL21 (DE3) pLysS was achieved by maintaining the cultures at
16 ◦C overnight after induction. The FtRelA purification required
two chromatographic steps with the initial purification using Ni-
IDA affinity chromatography (Figure 2A). SDS/PAGE analysis
showed a distinct band corresponding to the expected molecu-
lar mass (74 kDa) of FtRelA alongside several minor impurities
(Figure 2B). FtRelA was further purified in a polishing step, us-
ing size exclusion chromatography (Superdex 200, Figures 2C
and 2D). The resultant highly purified FtRelA was isolated in
a yield of 12 mg/ g cell pellet and could be concentrated up to
10 mg/ml (∼100 μM).
Multimeric state of purified FtRelA
The multimeric state of purified FtRelA was determined us-
ing size exclusion chromatography and comparison with protein
standards. FtRelA was shown to form one distinct peak which
had an apparent mass of 128 +− 1.57 kDa that approximately cor-
responds to a dimer state (calculated molecular mass of 148 kDa;
Figure 3).
Substrate specificity of FtRelA
As other RSH enzymes have been shown to utilize GDP and GTP
as pyrophosphate acceptors [30–33], the specificity of FtRelA for
these nts was investigated. End-point FtRelA activity assays were
prepared with FtRelA, ATP and either GDP, GTP or, as a negative
control CTP (Supplementary Figure S2). Efficient formation of
AMP and the 3′-pyrophosphorylated product were only observed
in the presence of GTP as a co-substrate (Figure 4; Supplement-
ary Figure S2); GDP and CTP were not accepted as substrates.
Very low concentrations of AMP are still measurable for activ-
ity assays with GDP as a pyrophosphate acceptor (Figure 4),
but the formation of ppGpp is not observed. FtRelA remained
selective for GTP as a pyrophosphate acceptor in the presence
of stalled ribosomal complexes (Supplementary Figure 3A) but
accepted GDP as a substrate in the presence of methanol (30 %
v/v, Supplementary Figure 3B)
Kinetic characterization of FtRelA basal activity
analysed by IP RP HPLC
To obtain steady state kinetic parameters for FtRelA, a series of
reaction time course experiments over a range of substrate con-
centrations were prepared. For time course experiments, initial
rates resulting in less than 15 % turnover of substrate were determ-
ined from HPLC quantification of products in aliquots withdrawn
at 0, 10, 20 and 40 min (Figure 5A; Supplementary Table S1). The
HPLC analysis provided measurements of the products concen-
trations: the AMP peak was clearly resolved, however slow de-
gradation of pppGpp (5′-triphosphate-3′-diphosphate guanosine)
to ppGpp resulted in two partially overlapping peaks, which were
combined to give an overall (p)ppGpp concentration (Supple-
mentary Figure S4). A better fit of the velocity curves (plot-
ting rate against concentration of substrate) was achieved for a
sigmoidal (R2 = 0.947) rather than a hyperbolic function (R2
= 0.899) for AMP production (Figures 5B and 5C; Table 1).
The Lineweaver–Burk plot for FtRelA steady state data was
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Figure 2 The purification of FtRelA by sequential Ni-IDA and size exclusion chromatography steps
(A) Absorption trace (280 nm) for the Ni-IDA purification of FtRelA. (B) SDS/PAGE analysis of FtRelA Ni-IDA purification.
Lanes: 1, cleared lysate; 2, flow through; 3–7, eluate fractions from Ni-IDA chromatography. (C) Absorption trace (280 nm)
for the size exclusion (Superdex 200) chromatography purification of FtRelA. (D) SDS/PAGE analysis of FtRelA purification.
Lanes: 1–8, eluate fractions from size exclusion chromatography; those marked with * correspond to the peak similarly
marked in (C).
Figure 3 Analysing the multimeric state of purified FtRelA
(A) Absorption trace (280 nm) for size exclusion chromatography (Superdex 200) yielding a single peak with an apparent
molecular mass of 128 +− 1.57 kDa corresponding to the dimeric state of the enzyme (calculated molecular mass of dimer
148 kDa). (B) Calibration curve for apparent molecular mass determination.
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Figure 4 Substrate specificity of FtRelA
FtRelA activity assays, with either GTP (solid black line) or GDP (dashed
green line) as the pyrophosphate acceptor, were stopped after 1 h and
analysed by IP RP-HPLC.
observed to curve in a manner consistent with positive co-
operativity [34] (Figure 5D). Fitting to eqn. (1) yielded the kinetic
parameters in Table 1 including K1/2 which denotes the concen-
tration of substrate at which half the maximal activity of the
enzyme is achieved. The K1/2 values for ATP as a substrate are
within error when calculated from rate of formation of AMP
or (p)ppGpp, with values of 259 +− 37.2 μM and 332 +− 47.8 μM
respectively. The K1/2 values for GTP as a substrate when calcu-
lated from AMP or pppGpp formation are 800.7 +− 115.6 μM
and 1095 +− 183.8 μM respectively, which are also within
error.
Kinetic characterization of FtRelA basal activity by
[31P]-NMR
As the sigmoidal saturation kinetic profile of FtRelA observed
by HPLC analysis is somewhat unusual, we sought to verify it
using [31P]-NMR as an alternative measurement technique. Des-
pite NMR not often being suitable for monitoring enzymatic
reactions, due to its intrinsic low sensitivity and resultant long
acquisition times, the relatively slow turnover of FtRelA in the
absence of activators (as judged by HPLC analysis) suggested
[31P]-NMR might also provide a useful approach for this en-
zyme. Using nt standards dissolved in enzyme assay buffer, the
signals for each phosphorus atom in the substrates and products
were identified (Supplementary Table S2). In preliminary NMR
experiments, some of these signals were observed to overlap in-
cluding those for the 5′-α and 3′-α of ppGpp (∼6 ppm). The signal
for the α-phosphate of AMP (3.32 ppm; Supplementary Figure
S5) however was well resolved. Despite the formation of an in-
dividual peak for the 5′-β phosphate of pppGpp (–19.88 ppm;
Supplementary Figure S5), the observed overlap with the neigh-
bouring peak (5′-β phosphate of GTP/ATP) and slow hydrolytic
conversion of pppGpp to ppGpp resulted in an increased error in
measuring pppGpp formation. This resulted in the higher derived
rates and apparent Vmax determined from calculated initial rates
of pppGpp formation (Figure 5).
The conversion of GTP to pppGpp was shown to occur in a
highly specific manner, with only one minor by-product being
observed, inorganic phosphate (1.94 ppm; Supplementary Figure
S5), which accumulates during the activity assays. This observa-
tion is consistent with either the instability of pppGpp under assay
conditions or the presence of a very low level of contaminating
phosphatase activity [35].
The intrinsic insensitivity of [31P]-NMR results in a relat-
ively weak signal, but 22-min spaced time points partly com-
pensated for this. However, the resultant data come with a caveat
that a significant proportion of the substrates (∼30 %) had been
turned over by the third time point (66 min). Somewhat surpris-
ingly, these [31P]-NMR time courses (Supplementary Figure S6)
showed approximate linearity in product formation to at least
1 h and reaction rates were calculated within this linear range
(Supplementary Figure S7; Supplementary Table S3). The rates
determined at a selected range of substrate concentrations were
plotted to yield velocity curves (Figures 5E and 5F). Once again,
these fitted to a sigmoidal function comparable to the results
observed with IP RP HPLC analysis of FtRelA activity assays,
including the K1/2 and Vmax for GTP and ATP (Supplementary
Table S4). Data obtained by [31P]-NMR should however be con-
sidered as an estimate only, due to the higher than normal pro-
portion of substrate turnover measured. Kinetic data sets meas-
ured by [31P]-NMR and HPLC were fitted to eqn (1) with Vmax
and K1/2 as global (shared) constants to derive overall kinetic
parameters (Table 2; Supplementary Figure S8). For the reasons
previously discussed, the initial rates calculated by [31P]-NMR
analysis of pppGpp formation were omitted from this global
fit.
Activation of FtRelA by small molecules
Shyp et al. [14] have described the positive regulation of E. coli
RelA (EcRelA) by the product of GDP pyrophosphorylation, pp-
Gpp [14]. Kinetic analysis using both HPLC and [31P]-NMR
methods showed positive co-operativity of FtRelA activity and it
was of interest to determine if small molecules such as ppGpp or
other small ligands were regulating activity. The effect of adding
putative activating factors, AMP, phosphate or ppGpp prior to
initiating the activity assay at low (10 μM), medium (100 μM)
or high (1000 μM) concentrations on the rate of product forma-
tion was measured using IP RP HPLC analysis. The background
concentration of additional ppGpp or AMP was subtracted to
give the concentration of each product newly formed during
the experiment. No significant activation was observed in the
presence of additional inorganic phosphate (KH2PO4) or AMP
(Figure 6A); however, in the presence of medium to high con-
centrations of ppGpp, activation was observed. Repeating this
activation measurement over a wider range of ppGpp concentra-
tions (0–1000 μM) allowed determination of an EC50 for ppGpp
of 60 +− 1.9 μM (Figure 6B) and a maximal 1.5-fold activation,
similar to the approximate 2-fold activation observed for EcRelA
[14].
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0. 7
R.C. Wilkinson and others
Figure 5 Kinetic analysis of FtRelA Activity
(A) Time courses of AMP formation at varying GTP concentrations in FtRelA activity assays determined by HPLC analysis;
0.25 mM (red), 0.4 mM (blue), 0.75 mM (green), 1 mM (lilac), 1.25 mM (orange), 1.75 mM (black), 2.75 mM (violet).
(B) Saturation activity curves for ATP substrate, measured using HPLC analysis. (C) Saturation activity curves for GTP
substrate, measured by HPLC analysis. (D) Lineweaver–Burk plot for FtRelA calculated for ATP (black line) and GTP (green
line) when analysed by IP RP HPLC. (E) Saturation activity curves for ATP substrate, measured by [31P]-NMR analysis. (B)
Saturation activity curves for GTP substrate, measured by [31P]-NMR analysis. All saturations curves using rates derived
from AMP formation are denoted with a black line and those derived from (p)ppGpp formation are denoted with a green
line.
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Table 1 Kinetic parameters derived from HPLC analysis of FtRelA activity assays
for GTP and ATP substrates. R2 is a measure of goodness of fit
The apparent Hill constant, h, is defined in equation 1 (above).
Substrate ATP GTP
Product measured AMP (p)ppGpp AMP (p)ppGpp
Vmax/× 10− 3 s− 1 9.46 +− 0.77 9.83 +− 0.82 10.59 +− 0.89 11.54 +− 1.5
K1/2/μM 259 +− 37.2 332 +− 47.8 800.7 +− 115.6 1095 +− 183.8
h 2.17 +− 0.7 2.71 +− 0.96 2.18 +− 0.53 3.07 +− 1.29
R2 0.95 0.94 0.97 0.93
Figure 6 Activation of FtRelA by potential small-molecule activators
(A) Graph shows enzyme activity when incubated with low (10 μM), medium (100 μM) and high concentrations (1000 μM)
of AMP (black), inorganic phosphate (white) or ppGpp (grey) in addition to substrates. (B) Dose-response (variable slope)
curve for activation of FtRelA by ppGpp.
Table 2 Calculated kinetic parameters for FtRelA when a global
fit is applied to both [31P]-NMR (AMP) and IP RP HPLC (AMP and
pppGpp) data sets. R2 is a measure of goodness of fit.
The apparent Hill constant, h, is defined in equation 1 (above).
Substrate ATP GTP
Vmax/× 10− 3 s− 1 10.79 +− 0.59 12.6 +− 1.19
K1/2/μM 344.3 +− 33.95 1026 +− 134.5
h 2.26 +− 0.44 2.58 +− 0.70
R2 0.932 0.881
Activation of FtRelA by stalled ribosomal
complexes
Bio-safety considerations encouraged us to explore alternatives
to F. tularensis as sources for ribosome isolation. Two alternat-
ive ribosome sources were investigated. Firstly, the well charac-
terized E. coli MRE600 strain which lacks ribonuclease I [36]
and has consequently been widely used for ribosome purific-
ation [26,37,38]. Secondly, another member of the Francisella
genus, F. philomiragia, which is of low virulence [39] and also
encodes within its genome a RelA enzyme lacking the ACT do-
main in its C-terminus [4]. Maguire et al. [26] developed an
affinity chromatography method for ribosome purification using
cysteine coupled SulfoLink resin (Pierce). Previous purification
of ribosomes from clinical isolates of pathogenic bacteria using
this method [26], suggested its potential use for the isolation of
ribosomes from F. philomiragia. Ribosomes were isolated from
bacterial cells collected from early-mid logarithmic phase cul-
tures, as established by growth curves (Supplementary Figure
S9), to ensure the optimal recovery of ribosomes. The protein
and RNA content of purified ribosomes were analysed primar-
ily by SDS/PAGE and absorbance traces at 260 and 280 nm
(Figure 7; Supplementary Figure S10). Purification of ribosomes
by this method can contain tRNA, which is thought to also interact
with the resin [40]. Contaminating tRNA was removed from ri-
bosomal preparations by ultrafiltration. Purified E. coli MRE600
ribosomes were shown to contain all ribosomal RNA species by
bleach agarose gel electrophoresis (Supplementary Figure S10
B); however, purified RNA from F. philomiragia proved too un-
stable for analysis by this method.
End-point (1 h) activity assays for both EcRelA and FtRelA
were prepared containing one of the following: F. philomiragia
ribosomes, E. coli ribosomes or in the absence of any ribosomes.
Rates are shown in units of picomoles AMP per picomoles RelA
per minute (Figure 8) to allow comparison with previously pub-
lished data for activated EcRelA [41]. Both EcRelA and FtRelA
demonstrated basal levels of activity in the absence of stalled
ribosomes, as has been noted previously for EcRelA and RelMtb
[42,43]. FtRelA displayed strong activation by E. coli ribosomes,
with an 11-fold increase in activity compared with the basal level
(Figure 8). We were unable however to show strong activation
of FtRelA in the presence of F. philomiragia ribosomes, with
only a modest 1.39-fold increase observed (Figure 8). Conversely
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Figure 7 Purification of F. philomiragia ribosomes by SulfoLink-
cysteine chromatography
(A) Absorption traces at 260 nm (blue trace) and 280 nm (red trace) for
fractions collected during purification. (B) SDS/PAGE analysis of F. philo-
miragia ribosome purification. Lanes: 1, cleared lysate; 2, flow through;
3–12, eluate fractions from SulfoLink-cysteine chromatography; those
marked with * relate to the peak similarly marked in (A).
EcRelA showed strong activation in the presence of either F.
philomiragia, with an 11-fold increase or E. coli ribosomes with a
16-fold increase, respectively (Figure 8). Maximal FtRelA activ-
ity (701.5 +− 30.5 pmol AMP per pmol RelA per min) did not
reach that of EcRelA (2952 +− 99.14 picomoles AMP per pico-
moles RelA per minute) under any conditions tested.
DISCUSSION
Virtually ubiquitous across bacterial species, the stringent re-
sponse is co-ordinated by signalling molecules (p)ppGpp and is
important in bacterial survival under nutrient deficient conditions.
In β- and γ -proteobacteria, the principle enzyme responsible for
(p)ppGpp synthesis is RelA [4] and yet research on this enzyme
has focused almost exclusively on E. coli RelA as a model enzyme
[11–13,30]. In the present study, we discuss the relevance of the
distinctive synthetase active-site motif and C-terminal truncation
within FtRelA in the functional similarities and differences when
compared with other defined RelA enzymes.
Purification of this enzyme by nickel affinity chromatography
followed by size exclusion chromatography yielded highly puri-
Figure 8 Activation of RelA by stalled ribosomal complexes
Activation of FtRelA and EcRelA by stalled ribosomal complexes com-
prises either F. philomiragia ribosomes or E. coli MRE600 ribosomes,
compared with basal RelA activity.
fied RelA, which could be concentrated to a 10-fold higher con-
centration than that reported for E. coli RelA [13]. The higher
solubility of FtRelA may be of practical value in future crystal-
lization studies.
Previous work with E. coli RelA has demonstrated the en-
zyme’s ability to dimerize via its C-terminal region [17,18]. The
ability of FtRelA to therefore dimerize was of interest given its
truncated C-terminus. In the present study however, we demon-
strate that FtRelA forms a stable dimer upon purification. We pos-
tulate that the presence of the identified key residues for EcRelA
dimerization Cys612, Asp637 and Cys638 [17] in FtRelA facilitate
the formation the dimer without the requirement of downstream
residues. We note that this may not however be FtRelAs nat-
ural multimeric state and might relate in the present study to the
high protein concentration. Further analysis of FtRelA dimeric
state over a range of concentrations may elucidate the enzymes
multimeric state at concentrations closer to those found in vivo.
Previous work on synthetase activity in long RSH enzymes
from E. coli [30], Mycobacterium tuberculosis [44] and Bacil-
lus subtilis [31] has demonstrated a preference for either GDP
or GTP as a substrate but invariably both are accepted. Data
presented in the present paper details the first example of a RelA
enzyme which has an explicit specificity for one of these two main
pyrophosphate acceptors. This specificity was also observed un-
der activating conditions with stalled ribosomal complexes but
interestingly not when FtRelA was activated with the primary al-
cohol methanol (Supplementary Figure S3). The effect of meth-
anol on protein conformation has been previously demonstrated
to strengthen hydrogen bonds and weaken hydrophobic interac-
tions [45]. Structural alterations to the synthetase-active site by
methanol could therefore account for the acceptance of GDP as
a pyrophosphate acceptor under these conditions and suggests
the EXSD motif contributes to substrate specificity along with
other structural elements of the synthetase domain. The potential
importance of the structural transition in a putative catalytic loop
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within the synthetase domain of bi-functional enzymes with an
RXKD motif has previously been reported [22]. It is therefore
tempting to speculate that the EXSD motif contributes to the ob-
served substrate specificity, although mutational analysis would
be required to provide evidence for this. With equal Mg2 + con-
centrations across all activity assays, the acceptance of GDP in
the presence of methanol leads us to suggest that the magnesium
concentration is unlikely to be the dominant factor in determin-
ing this specificity. Further work will be required to elucidate the
functional significance of this catalytic loop in RelA enzymes
with the unusual EXSD motif.
Kinetic analysis of the EcRelA in the absence of full activa-
tion has shown typical Michaelis–Menten kinetics [22,30]. In the
present study, we demonstrate the kinetic profile for the FtRelA
in the absence of activating factors fits a sigmoidal curve and
yields the derived kinetic parameters (termed Vmax and K1/2).
Measurement of both the nt products AMP and the (p)ppGpp
by HPLC analysis gave comparable sigmoidal fits and calculated
kinetic parameters. The observed sigmoidal curve was verified
by a second technique, [31P]-NMR spectroscopy, which yielded
comparable kinetic parameters when calculated using AMP pro-
duction for rate determination. The global fit of data gave a sig-
moidal curve with an R2 value of 0.93 and 0.88 for ATP and GTP
respectively (with a worse fit resulting from a hyperbolic curve,
R2 = 0.85). A sigmoidal curve has been observed for the bi-
functional long RSH enzyme, RelMtb, synthetase activity in the
absence of activating factors [22]. This kinetic profile was linked
to the RXKD motif found in the synthetase active site [22].
The substrate specificity and co-operative kinetic effects dur-
ing (p)ppGpp synthesis by FtRelA more closely resembles that
of bi-functional RSH enzymes rather than that of other RelA en-
zymes. Collectively, these data demonstrate a divergence from the
current classification system used for RelA enzymes [4,22] and
may indicate that FtRelA is instead an example of a new distinct
sub-class of RelA enzymes within the protein superfamily.
Several mechanisms can account for a sigmoidal velocity
curve, including the interesting possibility of allosteric regulation
[46]. In 2012, Shyp et al. [14] suggested ppGpp was responsible
for positive feedback regulation of E. coli RelA by allosteric
activation. ACT domains have been shown to regulate enzyme
catalytic activity by the downstream effects of binding small mo-
lecules, namely amino acids [19]. The regulatory small molecule
involved in binding the ACT domain of RelA enzymes has yet
to be identified. FtRelA is one of only three RelA enzymes to
not contain this domain [4], therefore the observation of FtRelA
activation by ppGpp (Figure 6) is highly indicative that ppGpp is
not the regulatory ligand for RelA enzymes ACT domains.
Experiments with FtRelA demonstrated that the (p)ppGpp
synthetase activity could be stimulated in vitro by the presence of
stalled ribosomal complexes formed with ribosomes from altern-
ative species (Figure 8), as has been observed previously for RSH
enzymes [47]. This weak activation of FtRelA however pales in
comparison with that achieved by EcRelA, with maximal activ-
ities of 701.5 +− 30.5 picomoles AMP per picomoles RelA per
minute and 2952 +− 99.14 picomoles AMP per picomoles RelA
per minute respectively (Figure 8). Conversely, strong activation
of EcRelA (in the range of levels previously reported [11,13]),
was observed in the presence of stalled ribosomal complexes
formed with either F. philomiragia or E. coli MRE600 ribosomes
(Figure 8). This strongly suggests that the observed lower sensit-
ivity of FtRelA to ribosomal activation is genuine and not related
to the quality of purified ribosomes or the use of heterologous
systems for ribosomal stalling. Key residues identified in EcRelA
involved in ribosomal binding were amino acids 550–682 [18].
At only 647 amino acids in length, FtRelA is missing ∼22 of
these identified residues involved in EcRelA ribosomal binding
[18] and this could account for the weaker activation observed
for FtRelA by stalled ribosomal complexes. Future studies may
identify the mechanistic relationship between this truncation and
the observed reduced activation of FtRelA.
CONCLUSIONS
FtRelA contains a variety of amino acid sequence differences
when compared with a wide range of other RelA enzymes, in-
cluding a truncated C-terminus and an alternative EXSD active
site motif. The current model for all RelA enzymes has been
based on that from E. coli. In the present study, we describe the
similarities and differences of FtRelA compared with the accep-
ted model. Observed differences include the specificity of FtRelA
for the pyrophosphate acceptor GTP (except in the presence of
methanol). Furthermore, the sigmoidal steady state kinetics ob-
served for FtRelA are unlike those reported for EcRelA, but sim-
ilar to that observed for the bi-functional RSH enzyme RelMtb.
Conversely FtRelA behaves similarly to EcRelA in its apparent
ability to dimerize and its activation by both stalled ribosomal
complexes and nt ppGpp. Comparison of the degree of activation
by stalled ribosomal complexes for FtRelA and EcRelAs suggest
the Francisella enzyme is more weakly activated. A deeper un-
derstanding of the underlying reasons behind the observed lower
activation and its value to Francisella species forms an interesting
objective for future research.
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